Skip to main content
. 2017 Jun 5;102(3):459–469. doi: 10.1002/cpt.726

Table 4.

Potential risk factors for vancomycin nephrotoxicity

Vancomycin exposure variables Loading dose
Total daily dose
AUC
Trough level
Duration
Continuous vs. intermittent infusion
Patient‐specific factors Obesity
Severity of illness
ICU residence
Chronic kidney disease
Concurrent nephrotoxin exposure
Concurrent aminoglycosides Concurrent piperacillin‐tazobactam